ArticleOncogene2026

DTX3 promotes anti-tumor immunity by inducing PD-L1 ubiquitination and is suppressed by p65/miR-222 in bladder cancer.

Yu Cheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.